Airway and systemic inflammation and decline in lung function in patients with COPD. - Wikidata - awgldk - TriplyDB

Airway and systemic inflammation and decline in lung function in patients with COPD.

Airway and systemic inflammation and decline in lung function in patients with COPD.

http://www.wikidata.org/entity/Q47707074

about

Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010 Comparing antibiotics for acute exacerbations of chronic obstructive pulmonary disease Comparing antibiotics for acute exacerbations of chronic obstructive pulmonary disease Fine particulate matter in acute exacerbation of COPD Contribution of air pollution to COPD and small airway dysfunction Lung function abnormalities in HIV-infected adults and children Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury Gene promoter methylation is associated with lung function in the elderly: the Normative Aging Study Chronic obstructive pulmonary disease patients have greater systemic responsiveness to ex vivo stimulation with swine dust extract and its components versus healthy volunteers Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.The association between systemic inflammatory cellular levels and lung function: a population-based study.IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches From proteomics to prescription-the search for COPD biomarkers.The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: a systematic review.Lower airway disease in asthmatics with and without rhinitis.Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations.Daily activity during stability and exacerbation of chronic obstructive pulmonary disease Associations of IL6 polymorphisms with lung function decline and COPD.Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.Evaluation of von Willebrand factor in COPD patients.Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis.Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.Inflammatory biomarkers in sputum predict COPD exacerbations.Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.Admission prevention in COPD: non-pharmacological management Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.

P2860

Q23914158-9FE6132A-AC65-4591-8454-DABA662BB383 Q24234366-1FEC94E6-47A1-4905-9687-970854F2923E Q24243833-942CA66F-495D-47FE-B426-88403F9EA0EB Q26777960-42AD0B90-826B-4438-9146-5966C47C4FF5 Q26786159-22BEE49B-1F54-49FD-814D-DF418C2BFC21 Q26863389-46512944-5E81-4ABB-B299-B80B24540487 Q27000043-44E581B0-BEAA-499A-9935-4389777E839C Q27329908-989DA10B-8399-4989-8ACF-E995C3178279 Q28383778-A6113A65-F524-460B-B893-EB9172CF03A7 Q28384754-E24A1E07-F296-4F34-ABB2-0E8ADAD1BE1C Q30480513-9523A81C-A068-477C-91E4-FF55280FA210 Q31025999-DE87B27C-51E5-45C7-9FE0-4E9D77E47FA9 Q33416183-36EA7445-54F2-4241-9226-6BF3E31E6A9D Q33430526-400C2E79-213A-485E-B3CD-8891AA124A20 Q33509146-894CAD4D-A619-4C97-A3C0-D1749831EE45 Q33574035-87C3E5B9-4923-4673-920C-5350DCED12C3 Q33679919-51B5D39D-B25B-4412-A08D-4057F538694D Q33704363-16617C34-D2EC-45C8-BBE4-1D95C4AAE5A0 Q33732176-2C266296-05CC-4549-9C76-111139667671 Q33755148-7037236F-17FE-45DA-912B-7F83675B57CE Q33755164-D03F59FD-B8FE-4F42-BF0E-9CCB3E29560F Q33808582-2368168B-FE63-4EB0-A78B-02A0FD6E39FA Q33995697-C47BAB41-E1BA-4154-896A-AD963E1E3628 Q34005625-F7646E9A-7F7B-408B-825A-1F127CF69903 Q34145804-7008AF87-C1AA-42FA-B92C-DCDCCC2194D0 Q34350843-F1B4469C-3654-474E-99D6-6232C37DDC0A Q34352974-74A0532E-ABE6-4C56-A41A-7FDA9C78B65B Q34360211-E9019DD2-DFC3-426A-ADB8-779BAE34C986 Q34386841-110BCE91-556B-4874-8ACC-636D776A1CF8 Q34425006-CAEC0EB8-0F2A-44F4-96D9-7EABFB5DF11E Q34636461-A912AECB-2527-4173-864A-E9BDE3A55868 Q34684239-05FA35AD-D29A-4D22-945C-B7141A603789 Q34693098-45E8FE87-3978-4FF9-9773-5B92CF88D94C Q34729530-AF958541-AF6F-48D5-8166-77CBB8F0188B Q34767932-76E47729-A2AF-4C02-87BE-3CD5D1BF4076 Q34840845-CC843FAE-F739-4027-9F3B-F3DBEB5C5D4F Q35046919-E684F384-7BA2-4622-9301-5BE58381A816 Q35225129-80992585-506E-4D57-8EAF-7941A5B93704 Q35532191-993CAB6F-483A-4648-8DE1-40E879EBE195 Q35575654-1A230D1F-A887-41DB-A2C3-11218633BB2A

P2860

Airway and systemic inflammation and decline in lung function in patients with COPD.

http://www.wikidata.org/entity/Q47707074

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Airway and systemic inflammation and decline in lung function in patients with COPD.

@en

Airway and systemic inflammation and decline in lung function in patients with COPD.

@nl

type

label

Airway and systemic inflammation and decline in lung function in patients with COPD.

@en

Airway and systemic inflammation and decline in lung function in patients with COPD.

@nl

prefLabel

Airway and systemic inflammation and decline in lung function in patients with COPD.

@en

Airway and systemic inflammation and decline in lung function in patients with COPD.

@nl

P1433

Q47707074-EDEB8DFE-2676-4B1C-95EE-75A6A46B7E75

P1476

Q47707074-47CBE714-BC0A-413E-B11D-79BD8847A4A2

P2093

Q47707074-48995362-BE29-4894-A491-E9C9A949DB39

Q47707074-5FA73629-75BA-461A-831E-86D64BDD738D

Q47707074-6E10F9AD-6117-4A93-B9C1-B5956DF2CFAD

Q47707074-88A263B4-EFD0-479B-9A41-AB060075BB75

Q47707074-9BD073CA-87D9-47CD-B0CD-D0FCE1711B74

Q47707074-D07A14F9-486D-407A-B67C-03AE09178E42

Q47707074-EE16A52F-D086-49EC-A2EF-F1E664B01CA5

Q47707074-F57B63BD-050D-4414-8CA5-109DC4D8F8FA

P304

Q47707074-B89CB0CD-9359-46B1-A298-B38B0F7DC9F0

P31

Q47707074-B164562F-5A81-4E1C-9F0B-0183F888184C

P356

Q47707074-B2A4C684-5287-4C74-9376-3B06A9FD6411

P407

Q47707074-AA79B7CE-5C42-4DE1-B743-6EA1753D2193

P433

Q47707074-E8BE8C4C-0221-49F0-8F3F-C7D0B5D11AAE

P478

Q47707074-EBA28B1A-FCC3-4FD2-964B-FA9806631959

P577

Q47707074-B89F15DA-A0F0-41F7-B14C-FCA435C5FAD9

P698

Q47707074-ED693A07-27DA-426E-83D1-0A6486228FD2

P921

Q47707074-C66BAFA5-85B5-4B49-828E-911C26DF5A30

Q47707074-F57645A7-742B-48BE-9BDF-7ED90A9B55B7

P356

CHEST.128.4.1995

P1433

P1476

Airway and systemic inflammation and decline in lung function in patients with COPD.

@en

P2093

Angshu Bhowmik

http://www.w3.org/2001/XMLSchema#string

Gavin C Donaldson

http://www.w3.org/2001/XMLSchema#string

Irem S Patel

http://www.w3.org/2001/XMLSchema#string

Jadwiga A Wedzicha

http://www.w3.org/2001/XMLSchema#string

John R Hurst

http://www.w3.org/2001/XMLSchema#string

Peter K Maccallum

http://www.w3.org/2001/XMLSchema#string

Terence A R Seemungal

http://www.w3.org/2001/XMLSchema#string

Tom M A Wilkinson

http://www.w3.org/2001/XMLSchema#string

P304

1995-2004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.128.4.1995

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16236847

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease